Simplex Trading’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-111,000
| Closed | -$6.52M | – | 10303 |
|
|
2023
Q4 | $6.52M | Hold |
111,000
| – | – | ﹤0.01% | 1361 |
|
|
2023
Q3 | $4.83M | Sell |
111,000
-8,700
| -7% | -$311K | ﹤0.01% | 1379 |
|
|
2023
Q2 | $4.32M | Buy |
119,700
+97,400
| +437% | +$4.01M | ﹤0.01% | 1416 |
|
|
2023
Q1 | $829K | Sell |
22,300
-70,900
| -76% | -$3.19M | ﹤0.01% | 2760 |
|
|
2022
Q4 | $4.22M | Buy |
93,200
+76,900
| +472% | +$4.98M | ﹤0.01% | 1324 |
|
|
2022
Q3 | $1.14M | Sell |
16,300
-112,800
| -87% | -$8.35M | ﹤0.01% | 2516 |
|
|
2022
Q2 | $8.67M | Buy |
129,100
+122,100
| +1,744% | +$7.76M | 0.01% | 873 |
|
|
2022
Q1 | $575K | Sell |
7,000
-9,900
| -59% | -$1.01M | ﹤0.01% | 3664 |
|
|
2021
Q4 | $2.48M | Buy |
16,900
+7,600
| +82% | +$1.18M | ﹤0.01% | 1814 |
|
|
2021
Q3 | $1.55M | Hold |
9,300
| – | – | ﹤0.01% | 2495 |
|
|
2021
Q2 | $1.5M | Buy |
9,300
+9,085
| +4,226% | +$1.46M | ﹤0.01% | 2559 |
|
|
2021
Q1 | $3.68M | Sell |
215
-103
| -32% | -$20.4K | 0.01% | 1071 |
|
|
2020
Q4 | $6.98M | Buy |
318
+210
| +194% | +$45.4K | 0.01% | 766 |
|
|
2020
Q3 | $1.79M | Sell |
108
-2
| -2% | -$274 | ﹤0.01% | 1639 |
|
|
2020
Q2 | $1.25M | Sell |
110
-18
| -14% | -$1.75K | ﹤0.01% | 1939 |
|
|
2020
Q1 | $983K | Sell |
128
-22
| -15% | -$1.97K | ﹤0.01% | 1899 |
|
|
2019
Q4 | $1.93M | Sell |
150
-49
| -25% | -$4.73K | ﹤0.01% | 1507 |
|
|
2019
Q3 | $1.55M | Sell |
199
-66
| -25% | -$6.19K | ﹤0.01% | 1548 |
|
|
2019
Q2 | $2.73M | Sell |
265
-37
| -12% | -$2.88K | 0.01% | 1071 |
|
|
2019
Q1 | $2.21M | Buy |
302
+294
| +3,675% | +$20K | 0.01% | 1289 |
|
|
2018
Q4 | $33K | Sell |
8
-246
| -97% | -$9.8K | ﹤0.01% | 4939 |
|
|
2018
Q3 | $1.2M | Sell |
254
-4
| -2% | -$223 | ﹤0.01% | 1710 |
|
|
2018
Q2 | $1.27M | Buy |
258
+250
| +3,125% | +$9.44K | 0.01% | 1578 |
|
|
2018
Q1 | $7K | Sell |
8
-240
| -97% | -$6.66K | ﹤0.01% | 4391 |
|
|
2017
Q4 | $64K | Buy |
248
+192
| +343% | +$2.98K | ﹤0.01% | 2207 |
|
|
2017
Q3 | $11K | Buy |
+56
| New | +$324 | ﹤0.01% | 3718 |
|
|
2017
Q1 | – | Sell |
-31
| Closed | -$2K | – | 6941 |
|
|
2016
Q4 | $2K | Buy |
31
+10
| +48% | +$54 | ﹤0.01% | 5167 |
|
|
2016
Q3 | $4K | Sell |
21
-9
| -30% | -$48 | ﹤0.01% | 4539 |
|
|
2016
Q2 | $4K | Buy |
+30
| New | +$478 | ﹤0.01% | 4505 |
|
|
2016
Q1 | – | Sell |
-47
| Closed | -$4K | – | 6423 |
|
|
2015
Q4 | $4K | Sell |
47
-19
| -29% | -$671 | ﹤0.01% | 4088 |
|
|
2015
Q3 | $3K | Buy |
+66
| New | +$2K | ﹤0.01% | 4454 |
|
Other funds holding MRTX
Simplex Trading's MRTX Position: Q1 2024 in Review
Simplex Trading sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 49,585 shares — an estimated $2.91M sold.
Simplex Trading first reported a position in MRTX in Q2 2016 and held it in 21 quarters. The position peaked at $2.91M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Simplex Trading reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Simplex Trading sold 49,585 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.91M.
- Simplex Trading first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2016 and held it in 21 quarters.
- Simplex Trading's Mirati Therapeutics, Inc. Common Stock position peaked at $2.91M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.